J J Le Jeune - JoVE Visualize

Showing results (1-10 of 51) with videos related to

Pageof 6

Sort By:

European Journal of Nuclear Medicine|January 1, 1982

Emission computed tomography vs perfusion scanning in lung diseaseJ J Le Jeune, J Maublant, M Lahellec, et al.

Experimental Brain Research|May 6, 1999

Early detection of liposome brain localization in rat experimental allergic encephalomyelitisV Rousseau, B Denizot, J J Le Jeune, et al.

Bulletin De L'Association Des Anatomistes|March 1, 1994

[Transmission electron microscopy in the structural study of superparamagnetic contrast agents for MRI]I Lucet, R Filmon, D Pouliquen, et al.

Magnetic Resonance in Medicine|March 1, 1992

Investigation of the magnetic properties of iron oxide nanoparticles used as contrast agent for MRID Pouliquen, H Perroud, F Calza, et al.

Magma (New York, N.Y.)|November 14, 1997

Investigation of blood-brain barrier permeability to magnetite-dextran nanoparticles (MD3) after osmotic disruption in ratsV Rousseau, B Denizot, D Pouliquen, et al.

Magnetic Resonance Imaging|January 1, 1991

Iron oxide nanoparticles for use as an MRI contrast agent: pharmacokinetics and metabolismD Pouliquen, J J Le Jeune, R Perdrisot, et al.

Magnetic Resonance in Medicine|December 7, 2000

In vivo quantitative microimaging of rat spinal cord at 7TF Franconi, L Lemaire, L Marescaux, et al.

Journal of Neuro-Oncology|April 3, 1998

Glial tumoral proliferation induces changes in the state and physical properties of water during ENU-induction of brain tumors in ratsV Rousseau, D Pouliquen, F Darcel, et al.

Medical Physics|March 17, 2010

Susceptibility gradient quantization by MRI signal response mapping (SIRMA) to dephaserF Franconi, C Chapon, J J Le Jeune, et al.

Magma (New York, N.Y.)|October 30, 1998

NMR investigation of experimental chemical induced brain tumors in rats, potential of a superparamagnetic contrast agent (MD3) to improve diagnosisV Rousseau, D Pouliquen, F Darcel, et al.

Pageof 6

Showing results (1-10 of 51) with videos related to

Sort By:

Pageof 6

European Journal of Nuclear Medicine|January 1, 1982

Emission computed tomography vs perfusion scanning in lung diseaseJ J Le Jeune, J Maublant, M Lahellec, et al.

Experimental Brain Research|May 6, 1999

Early detection of liposome brain localization in rat experimental allergic encephalomyelitisV Rousseau, B Denizot, J J Le Jeune, et al.

Bulletin De L'Association Des Anatomistes|March 1, 1994

[Transmission electron microscopy in the structural study of superparamagnetic contrast agents for MRI]I Lucet, R Filmon, D Pouliquen, et al.

Magnetic Resonance in Medicine|March 1, 1992

Investigation of the magnetic properties of iron oxide nanoparticles used as contrast agent for MRID Pouliquen, H Perroud, F Calza, et al.

Magma (New York, N.Y.)|November 14, 1997

Investigation of blood-brain barrier permeability to magnetite-dextran nanoparticles (MD3) after osmotic disruption in ratsV Rousseau, B Denizot, D Pouliquen, et al.

Magnetic Resonance Imaging|January 1, 1991

Iron oxide nanoparticles for use as an MRI contrast agent: pharmacokinetics and metabolismD Pouliquen, J J Le Jeune, R Perdrisot, et al.

Magnetic Resonance in Medicine|December 7, 2000

In vivo quantitative microimaging of rat spinal cord at 7TF Franconi, L Lemaire, L Marescaux, et al.

Journal of Neuro-Oncology|April 3, 1998

Glial tumoral proliferation induces changes in the state and physical properties of water during ENU-induction of brain tumors in ratsV Rousseau, D Pouliquen, F Darcel, et al.

Medical Physics|March 17, 2010

Susceptibility gradient quantization by MRI signal response mapping (SIRMA) to dephaserF Franconi, C Chapon, J J Le Jeune, et al.

Magma (New York, N.Y.)|October 30, 1998

NMR investigation of experimental chemical induced brain tumors in rats, potential of a superparamagnetic contrast agent (MD3) to improve diagnosisV Rousseau, D Pouliquen, F Darcel, et al.

Pageof 6